| Primary |
| Acute Coronary Syndrome |
47.1% |
| Hyperlipidaemia |
29.4% |
| Hypercholesterolaemia |
11.8% |
| Atrial Fibrillation |
5.9% |
| Blood Cholesterol |
5.9% |
|
| Breast Cancer |
17.6% |
| Hepatic Enzyme Increased |
11.8% |
| Palpitations |
11.8% |
| Prostate Cancer |
11.8% |
| Bile Duct Stone |
5.9% |
| Dysarthria |
5.9% |
| Myalgia |
5.9% |
| Pain In Extremity |
5.9% |
| Renal Failure Acute |
5.9% |
| Urine Output Decreased |
5.9% |
| Visual Impairment |
5.9% |
| Vomiting |
5.9% |
|
| Secondary |
| Product Used For Unknown Indication |
40.4% |
| Hypercholesterolaemia |
9.1% |
| Drug Use For Unknown Indication |
7.7% |
| Hypertension |
7.4% |
| Suicide Attempt |
5.4% |
| Asthma |
4.0% |
| Acute Coronary Syndrome |
3.0% |
| Cerebrovascular Accident |
3.0% |
| High Density Lipoprotein Decreased |
3.0% |
| Dyslipidaemia |
2.7% |
| Arthralgia |
2.0% |
| Fungal Skin Infection |
2.0% |
| Diabetes Mellitus Inadequate Control |
1.7% |
| Prophylaxis Against Hiv Infection |
1.7% |
| Diabetes Mellitus |
1.3% |
| Hyperlipidaemia |
1.3% |
| Atrial Fibrillation |
1.0% |
| Blood Cholesterol Increased |
1.0% |
| Drug Withdrawal Syndrome |
1.0% |
| Fungal Infection |
1.0% |
|
| Completed Suicide |
13.2% |
| Death |
13.2% |
| Toxicity To Various Agents |
13.2% |
| Rhabdomyolysis |
7.5% |
| Asthma |
5.7% |
| Lichen Planus |
5.7% |
| Respiratory Arrest |
5.7% |
| Acute Lymphocytic Leukaemia |
3.8% |
| Rash Maculo-papular |
3.8% |
| Sinusitis |
3.8% |
| Stress Ulcer |
3.8% |
| Suicide Attempt |
3.8% |
| Tachycardia |
3.8% |
| Acute Generalised Exanthematous Pustulosis |
1.9% |
| Aspartate Aminotransferase Increased |
1.9% |
| Cardiogenic Shock |
1.9% |
| Chills |
1.9% |
| Condition Aggravated |
1.9% |
| Drug Toxicity |
1.9% |
| Enterocolitis Infectious |
1.9% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.8% |
| Hypertension |
20.9% |
| Rheumatoid Arthritis |
7.4% |
| Type 2 Diabetes Mellitus |
5.8% |
| Drug Use For Unknown Indication |
5.5% |
| Prophylaxis |
4.2% |
| Myocardial Infarction |
4.0% |
| Diabetes Mellitus |
3.2% |
| Hypercholesterolaemia |
3.2% |
| Atrial Fibrillation |
2.6% |
| Hyperlipidaemia |
2.6% |
| Depression |
2.4% |
| Rectal Cancer |
2.4% |
| Pain |
1.9% |
| Restless Legs Syndrome |
1.9% |
| Smoking Cessation Therapy |
1.9% |
| Blood Cholesterol |
1.6% |
| Chronic Obstructive Pulmonary Disease |
1.6% |
| Dyslipidaemia |
1.6% |
| Nasopharyngitis |
1.6% |
|
| Renal Failure Acute |
9.6% |
| Hypotension |
7.2% |
| Weight Increased |
7.2% |
| Myocardial Infarction |
6.0% |
| Swollen Tongue |
6.0% |
| Diarrhoea |
4.8% |
| Goitre |
4.8% |
| Oedema Peripheral |
4.8% |
| Oxygen Saturation Decreased |
4.8% |
| Pain |
4.8% |
| Pulmonary Embolism |
4.8% |
| Syncope |
4.8% |
| Wheezing |
4.8% |
| Bradycardia |
3.6% |
| Diplopia |
3.6% |
| Malaise |
3.6% |
| Nausea |
3.6% |
| Pain In Extremity |
3.6% |
| Pancreatitis Acute |
3.6% |
| Rash |
3.6% |
|
| Interacting |
| Product Used For Unknown Indication |
40.0% |
| Prostate Cancer Metastatic |
30.0% |
| Hypercholesterolaemia |
10.0% |
| Sinusitis |
10.0% |
| Urinary Tract Infection |
10.0% |
|
| Drug Interaction |
50.0% |
| Pancreatitis |
50.0% |
|
